Sekonder hiperparatiroidili hastalarda subtotal paratiroidektomi sonuçlarımız

Amaç: Sekonder hiperparatiroidi kronik böbrek yetmezliğinin en önemli geç dönem bulgularından biridir. Bu çalışmada amacımız kliniğimizde 4 yıllık süre içinde kronik böbrek yetmezliğine bağlı gelişen sekonder hiperparatiroidi nedeniyle ameliyat edilen olguların analizini ve klinik özelliklerini retrospektif olarak değerlendirmektir. Yöntem: Ocak 2001 ile Mart 2005 tarihleri arasında kliniğimizde kronik böbrek yetmezliği sonucu gelişen sekonder hiperparatiroidi nedeniyle subtotal paratiroidektomi uygulanan 14 hasta retrospektif olarak değerlendirildi. Bulgular: Hastalarda en sık rastlanan semptom kas güçsüzlüğü ve kemik ağrıları idi. Kas güçsüzlüğü 10 hastada, kemik ağrıları ise 8 hastada mevcut idi. Ameliyat öncesi yapılan radyolojik incelemede çekilen el grafisinde 8 hastada (% 57) subperiostal rezorbsiyon saptandı. Bir hastada ise spontan kemik kırığı tespit edildi. Serum kalsiyum düzeyleri ortalama 12.2± 0.9 (8.2-15.1) mg/dL, fosfor düzeyleri ortalama 6.3±1.8 (2.2-7.4) mg/dL, ALP düzeyi ise ortalama 873± 243,5 (225-8884) U/L olarak ölçüldü. Hastaların tümünde parathormon değeri yüksek bulundu. Ortalama PTH değeri 878 (810-1257) pgr/ml olarak ölçüldü. Tüm hastalarda paratiroid bezleri anatomik olarak normal pozisyonda idi ve hastaların tümüne subtotal paratiroidektomi uygulandı. Sonuç: Böbrek yetmezliğine bağlı sekonder hiperparatiroidi kalsiyum ve vitamin D tedavisine cevap vermesine rağmen uzun dönemde cerrahi tedavi önem kazanmaktadır. Subtotal paratiroidektomi uygulanan vakalarda klinik olarak belirgin iyileşme, laboratuar bulgularında düzelme görülmüş ve kalıcı hipoparatiroidi görülmemiştir. Kronik böbrek yetmezlikli hastalarda gelişen sekonder hiperparatirodi tedavisinde subtotal paratiroidektominin en uygun cerrahi tedavi olduğunu düşünmekteyiz.

Subtotal parathyroidectomy in the treatment of secondary hyperparathyroidism

Objective: Secondary hyperparathyroidism is the most important late term feature of chronic renal failure. In this study, our aim was to investigate cases operated for secondary hyperparathyroidism occurred by chronic renal failure in 4 years period and the clinical features retrospectively. Methods: Fourteen patients who were confirmed subtotal parathyroidectomy for secondary hyperparathyroidy occurred by chronic renal failure were examined between January 2001-March 2005 in our clinic. Results: The most seen symptoms were muscle weakness and bone ache in the patients. There was muscle weakness in 10 patients and bone ache in 8 patients. In 8 patients there was subperiostal resorbtion in hand graphics made before operation. Spontaneous bone break was identified in 1 patient. Average serum calcium levels were 12.2± 0.9 (8.2-15.1) mg/dL, mean phosphorus levels were 6.3±1.8 (2.2-7.4) mg/dL, and mean ALP levels were 873± 243,5 (225-8884) U/L. PTH levels were found high in all patients. Mean PTH value was measured as 878 pgr/ml (810-1257). All parathyroids were in normal position anatomically and subtotal parathyroidectomy was performed to all patients. Conclusion: Although secondary hyperparathyroidy due to renal failure good to calcium and vitamin D treatment, in long term treatment surgery becomes more important. Subtotal parathyroidectomy significant healing was seen clinically, laboratory findings got better and no permanent hypoparathyroidy was seen. We believe that subtotal parathyroidectomy is the most suitable surgical treatment in secondary hyperparathyroidy in patents with chronic renal failure.

___

  • 1. Sadler GP, Clark OH, van Herden JA, Farley DR. Thyroid and parathyroid. In: Schwartz SI, Shires GT, Daly JM, Fisher JE, Galloway AC (Eds). Principles of Surgery. 7th ed. New York. Mc Graw Hill, 1999, pp: 1706-7.
  • 2. Rothmund M, Wagner P. Total parathyroidectomy and autotransplantation of parathyroid tissue for renal hyperparathyroidism: One to six year follow-up. Ann Surg 1983;197:7-16.
  • 3. Clark OH. Persistent and recurrent hyperparathyroidism. In Cameron JL, ed. Current Surgical Therapy. 5th ed. Newyork: Mosby, 1997:529-33.
  • 4. Menerey K, Braunstein E, Brown M, Swartz R, Brown C, Fox JN. Musculoskeletal symptoms related to arthropathy in patients receiving dialysis. J Rheumatol 1988;15:1848-54.
  • 5. Stranbury SW, Lumb GA, Niholson WF. Elective subtotal parathyroidectomy for renal hyperparathyroidism. Lancet 1960;1:793-8.
  • 6. Ogg CS. Total parathyroidectomy in the treatment of secondary (renal) hyperparathyroidism. Br Med J 1967;4:331-4.
  • 7. Alveryd A. Parathyroid glands in thyroid surgery. Acta Chir Scand Suppl 1968; 389:1-120.
  • 8. Gonzales EA, Martin KJ. Renal osteodystrophy. Pathogenesis and management. Nephrol Dial Transplant 1995; 10:13-21.
  • 9. Cohen AS. Amyloidozis. In: Mc Carty DJ, Koopman WJ (eds): Arthritis and Allied Conditions. Lea and Febiger, Philadelphia, 1995: 1427-47.
  • 10. Spindler A, Paz S, Berman A, Lucero E, Contino N, Penalba A, et al. Muscular strength and bone mineral density in haemodialysis patients. Nephrol Dial Transplant 1997; 12:128-32.
  • 11. Brown EA, Arnold IR, Gower PE. Dialysis arthropathy: Complication of long term treatment with haemodialysis. Br Med J 1986;292:163-5.
  • 12. Majdalani G, Chomant J, Kachko A, Yanai M, Man NK. Kinetics of technetium labeled heparin in hemodialyzed patients. Kidney Int Suppl 1993; 41:131-4.
  • 13. Gonnelli S, Cepollaro C, Montagnani A, Monaci G, Campagna MS, Franci MB, et al. Bone alkaline phosphatase measured with a new immunoradiometric assay in patients with metobolic bone diseases. Eur J Clin Invest 1996;26:391-6.